Insider Buying: Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Director Purchases $54,150.00 in Stock

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Director Inderpal S. Bhandari acquired 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.

Walgreens Boots Alliance Stock Down 0.1 %

NASDAQ:WBA opened at $17.63 on Thursday. The stock has a 50 day simple moving average of $20.60 and a 200 day simple moving average of $21.98. Walgreens Boots Alliance, Inc. has a 1-year low of $17.53 and a 1-year high of $36.14. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. During the same period in the prior year, the company earned $1.16 EPS. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. SVB Leerink reduced their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research report on Monday, March 18th. Morgan Stanley cut their price objective on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a report on Monday, April 1st. UBS Group lowered their target price on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, April 3rd. TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. Finally, HSBC reissued a “reduce” rating and issued a $20.00 price objective (down previously from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $24.36.

Hedge Funds Weigh In On Walgreens Boots Alliance

A number of institutional investors and hedge funds have recently bought and sold shares of the company. EverSource Wealth Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares during the period. Highlander Capital Management LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter valued at approximately $26,000. Pineridge Advisors LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at $26,000. Venturi Wealth Management LLC lifted its holdings in shares of Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the period. Finally, FinTrust Capital Advisors LLC grew its stake in shares of Walgreens Boots Alliance by 2,314.5% in the third quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,273 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.